Kaitlyn Riffel is a Consultant of Global Regulatory Affairs for Cardinal Health Regulatory Sciences (CHRS) where she consults on drug, device, and biologic development. Kaitlyn holds a Master of Science in Integrative Pharmacology from Michigan State University College of Osteopathic Medicine, and a BS in Biochem from the University of Missouri. Prior to CHRS, she served as a research associate in vaccine development and as a scientist at a nonclinical contract research organization.